Tru Wealth Advisors, LLC Amgen Inc Transaction History

Tru Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$225.79 - $275.2 $509,833 - $621,401	2,258 Added 13.54%	18,940 $4.58 Million
Q4 2022 Jan 27, 2023	BUY	$229.03 - $291.01 $3.82 Million - $4.85 Million	16,682 New	16,682 $0
Q3 2021 Oct 29, 2021	SELL	$212.27 - $248.7 $175,971 - $206,172	-829 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $63,767 - $70,745	-273 Reduced 24.77%	829 $202,000
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $35,727 - $41,634	-161 Reduced 12.75%	1,102 $274,000
Q4 2020 Jan 26, 2021	BUY	$216.38 - $257.67 $273,287 - $325,437	1,263 New	1,263 $290,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Tru Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Wealth Advisors, LLC with notifications on news.